The long-term goal of this research is to decrease the morbidity and mortality related to diabetic vascular dysfunction and related complications, by developing novel, bioactive therapeutic agents. Hyperglycemia- induced vascular inflammation, leading to monocyte adhesion to vascular endothelial cells (ECs), is the key factor that initiates the pathogenesis of atherosclerosis in diabetic patients. Our studies found that botanical genistein inhibits hyperglycemia-induced human leukocyte-EC interaction, suggesting a potential anti- inflammatory action of genistein in diabetic vascular complications. Leukocyte adhesion to endothelium is mediated through both chemokines and adhesion molecules on ECs, and the expression of these molecules is critically up-regulated by nuclear factor kB (NF-kB). Further analysis showed that genistein suppressed high glucose-induced production of monocyte chemoattractant protein-1 (MCP-1) and interleukin-8 (IL-8) in human aortic ECs (HAECs), two chemokines that are the key factors in the firm adhesion of monocytes to activated ECs. Recent studies in this laboratory found that genistein is an activator of the cAMP signaling system in ECs. Interestingly, our studies showed that dietary intake of genistein increased plasma cAMP but reduced MCP-1 levels in diabetic mice.
Our specific aim of this proposal is to determine the molecular mechanism by which genistein suppresses hyperglycemia-induced vascular inflammation. We hypothesized that genistein, by activation of the cAMP/PKA signaling, inhibits high glucose-induced monocyte adhesion to ECs through suppression of NF-kB activity and subsequent inhibition of chemokine and adhesion molecule expression.
Specific aim 1 will use HAECs to investigate: 1) whether genistein inhibits hyperglycemia-induced expression of chemokines and adhesion molecules; 2) whether genistein inhibits hyperglycemia-induced NF-kB activity; and 3) whether the anti-inflammatory properties of genistein are mediated via the cAMP/PKA pathway.
Specific aim 2 will use diabetic mouse models to determine: 1) whether genistein induces cAMP/PKA signaling in vivo; 2) whether genistein inhibits chemokine and adhesion molecule production from blood vessels; and 3) whether genistein suppresses monocyte recruitment to vascular ECs. Genistein will be administered through a nutritional supplementation approach to both chemically induced and obese diabetic mice. The protein and mRNA expression will be assessed by Western blot, ELISA or real-time PCR. The adenylate cylase activity, cAMP and PKA activation in ECs will be determined using assay kits. NF-kB activity will be determined with ELISA and reporter gene assay. The role of the cAMP/PKA cascade in the anti-inflammatory action of genistein will be determined by using both pharmacological and molecular intervention approaches. The mechanistic understanding of how genistein protects against diabetes-caused vascular inflammation will facilitate the development of efficacious CAM strategies to protect diabetic patients from vascular complications. ? ?

Public Health Relevance

Cardiovascular disease such as atherosclerosis is the main cause of deaths in patients with diabetes mellitus. It is increasingly recognized that vascular inflammation mediated by sustained elevation of blood glucose levels in diabetic patients plays a pivotal role in the pathogenesis of atherosclerosis. Our studies indicate that botanical genistein is a promising agent to protect against chronic high glucose- caused vascular inflammation. The results of this research will potentially lead us to develop novel, natural, and cost-effective agents to prevent and treat atherosclerosis caused by diabetes, a chronic disease that affects over 20 million Americans. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Center for Complementary & Alternative Medicine (NCCAM)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21AT004694-01
Application #
7509977
Study Section
Special Emphasis Panel (ZAT1-DB (29))
Program Officer
Pontzer, Carol H
Project Start
2008-09-15
Project End
2010-08-31
Budget Start
2008-09-15
Budget End
2009-08-31
Support Year
1
Fiscal Year
2008
Total Cost
$198,125
Indirect Cost
Name
Virginia Polytechnic Institute and State University
Department
Nutrition
Type
Schools of Earth Sciences/Natur
DUNS #
003137015
City
Blacksburg
State
VA
Country
United States
Zip Code
24061
Si, Hongwei; Wyeth, Richard P; Liu, Dongmin (2014) The flavonoid luteolin induces nitric oxide production and arterial relaxation. Eur J Nutr 53:269-75
Fu, Zhuo; Yuskavage, Julia; Liu, Dongmin (2013) Dietary flavonol epicatechin prevents the onset of type 1 diabetes in nonobese diabetic mice. J Agric Food Chem 61:4303-9
Zhang, Yanling; Zhen, Wei; Maechler, Pierre et al. (2013) Small molecule kaempferol modulates PDX-1 protein expression and subsequently promotes pancreatic ?-cell survival and function via CREB. J Nutr Biochem 24:638-46
Jia, Zhenquan; Babu, Pon Velayutham Anandh; Si, Hongwei et al. (2013) Genistein inhibits TNF-?-induced endothelial inflammation through the protein kinase pathway A and improves vascular inflammation in C57BL/6 mice. Int J Cardiol 168:2637-45
Jia, Zhenquan; Zhen, Wei; Velayutham Anandh Babu, Pon et al. (2013) Phytoestrogen genistein protects against endothelial barrier dysfunction in vascular endothelial cells through PKA-mediated suppression of RhoA signaling. Endocrinology 154:727-37
Gilbert, Elizabeth R; Liu, Dongmin (2012) Epigenetics: the missing link to understanding ?-cell dysfunction in the pathogenesis of type 2 diabetes. Epigenetics 7:841-52
Fu, Zhuo; Gilbert, Elizabeth R; Pfeiffer, Liliane et al. (2012) Genistein ameliorates hyperglycemia in a mouse model of nongenetic type 2 diabetes. Appl Physiol Nutr Metab 37:480-8
Babu, Pon Velayutham Anandh; Si, Hongwei; Fu, Zhuo et al. (2012) Genistein prevents hyperglycemia-induced monocyte adhesion to human aortic endothelial cells through preservation of the cAMP signaling pathway and ameliorates vascular inflammation in obese diabetic mice. J Nutr 142:724-30
Babu, Pon V Anandh; Si, Hongwei; Liu, Dongmin (2012) Epigallocatechin gallate reduces vascular inflammation in db/db mice possibly through an NF-?B-mediated mechanism. Mol Nutr Food Res 56:1424-32
Si, Hongwei; Yu, Jie; Jiang, Hongling et al. (2012) Phytoestrogen genistein up-regulates endothelial nitric oxide synthase expression via activation of cAMP response element-binding protein in human aortic endothelial cells. Endocrinology 153:3190-8

Showing the most recent 10 out of 18 publications